A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors

Psychopharmacology

Volumn 212, Issue 4, 2010, Pages 585-595

  Randall Thompson, Jovita F ^a   Pescatore, Karen A ^a   Unterwald, Ellen M ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Anxiety; Central nucleus of the amygdala; Delta opioid receptor; DPDPE; Elevated plus maze; Naltrindole; SNC80; Swim stress

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NALTRINDOLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; FORCED SWIMMING TEST; LOCOMOTION; MALE; MAZE TEST; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; STRESS; TRANQUILIZING ACTIVITY;

AMYGDALA; ANALGESICS, OPIOID; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, D-PENICILLAMINE (2,5)-; FEAR; MALE; MICROINJECTIONS; MOTOR ACTIVITY; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SWIMMING; TIME FACTORS;

EID: 78651328841     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1980-y     Document Type: Article

References (47)

1. Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC, Porreca F (1995) SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther 273:359-366
2. Bishop SJ (2007) Neurocognitive mechanisms of anxiety: An integrative account. Trends Cogn Sci 11:307-316
3. Brown PL, Hurley C, Repucci N, Drugan RC (2001) Behavioral analysis of stress controllability effects in a new swim stress paradigm. Pharmacol Biochem Behav 68:263-272
4. Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, Vinken P, Ashton D, Langlois X, Steckler T (2004) Anxiolyticand antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur J Pharmacol 485:145-158
5. Chiba T, Murase H, et al (1996) Antinociceptive activity of deltorphin analogs in the formalin test. Life Sci 59(20):1717-1722
6. Chieng B, Christie MJ (2009) Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey. Neuropharmacology 57:430-437
7. Chieng B, Christie MJ, Osborne PB (2006) Characterization of neurons in the rat central nucleus of the amygdale: Cellular physiology, morphology, and opioid sensitivity. J Comp Neurol 497:910-927
8. Devine DP, Wise RA (1994) Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 14:1978-1984
9. Emmerson PJ, Liu MR, Woods JH, Medzihradsky F (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271:1630-1637
10. Fang L, Knapp RJ, Horvath R, Matsunaga TO, Haaseth RC, Hruby VJ, Porreca F, Yamamura HI (1994) Characterization of [3H] naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: Evidence for delta opioid receptor heterogeneity. J Pharmacol Exp Ther 268:836-846
11. Fanselow MS, Helmstetter FJ (1988) Conditional analgesia, defensive freezing, and benzodiazepines. Behav Neurosci 102:233-243
12. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gaveriaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25:195-200
13. Gallantine EL,Meert TF (2005) A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the deltaopioid agonist SNC80. Basic Clin Pharmacol Toxicol 97(1):39-51
14. Garakani A, Mathew SJ, Charney DS (2006) Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 73: 941-949
15. Hirata H, Sonoda S, Agui S, Yoshida M, Ohinata K, Yoshikawa M (2007) Rubiscolin-6, a delta opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating sigma1 and dopamine D1 receptors. Peptides 28:1998-2003
16. Israel Y, Kandov Y, et al (2005) NPY-induced feeding: Pharmacological characterization using selective opioid antagonists and antisense probes in rats. Peptides 26(7):1167-1175
17. Jutkiewicz EM (2006) The antidepressant -like effects of delta-opioid receptor agonists. Mol Interv 6:162-169
18. Kameyama T, Nagasaka M (1982) The effects of analgesics on quickly-learned conditioned suppression in mice. Neuropharmacology 21:1283-1289 (Pubitemid 13196691)
19. Kang W, Wilson SP, Wilson MA (1999) Changes in nociceptive and anxiolytic responses following herpes virus-mediated preproenkephalin overexpression in rat amygdala are naloxone-reversible and transient. Ann N Y Acad Sci 877:751-755
20. Kang W, Wilson SP, et al (2000) Overexpression of proenkephalin in the amygdala potentiates the anxiolytic effects of benzodiazepines. Neuropsychopharmacology 22(1):77-88
21. Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A (1996) Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383:535-538
22. Korte SM, DeBoer SF (2003) A robust animal model of state anxiety: Fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol 463:163-175
23. Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 18:22-29
24. Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83-244
25. Mosberg HI, Hurst R, Hruby VJ, Gee K, Yamamura HI, Galligan JJ, Burks TF (1983) Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A 80:5871-5874
26. Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, Suzuki T (2006a) Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31:739-750
27. Narita M, Kuzumaki N, Kaneko C, Tamai E, Khotib J, Miyatake M, Shindo K, Nagumo Y, Tanaka S, Suzuki T (2006b) Age-related emotionality is associated with cortical delta-opioid receptor dysfunction-dependent astrogliosis. Neuroscience 137:1359-1367 (Pubitemid 43133159)
28. Nieto MM, Guen SL, Kieffer BL, Roques BP, Noble F (2005) Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135:305-313
29. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Elsevier, Elsevier
30. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167
31. Perrine SA, Hoshaw BA, Unterwald EM (2006) Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol 147:864-872
32. Pollier F, Sarre S, Aguerre S, Ebinger G, Mormede P, Michotte Y, Chaouloff F (2000) Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality. Neuropsychopharmacology 22:64-76
33. Portoghese PS, Sultana M, Nagase H, Takemori AE (1988a) Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists. J Med Chem 31:281-282
34. Portoghese PS, Sultana M, Takemori AE (1988b) Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol 146:185-186
35. Primeaux SD, Wilson SP, McDonald AJ, Mascagni F, Wilson MA (2006) The role of delta opioid receptors in the anxiolytic actions of benzodiazepines. Pharmacol Biochem Behav 85:545-554
36. Ragnauth A, Schuller A, Morgan M, Chan J, Ogawa S, Pintar J, Bodnar RJ, Pfaff DW (2001) Female preproenkephalin-knockout mice display altered emotional responses. Proc Natl Acad Sci U S A 98:1958-1963
37. Ramos A, Berton O, Mormede P, Chaouloff F (1997) A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 85:57-69
38. Ramos A, Mellerin Y, Mormede P, Chaouloff F (1998) A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses. Behav Brain Res 96:195-205
39. Ramos A, Kangerski AL, Basso PF, Da Silva Santos JE, Assreuy J, Vendruscolo LF, Takahashi RN (2002) Evaluation of Lewis and SHR rat strains as a genetic model for the study of anxiety and pain. Behav Brain Res 129:113-123
40. Rodgers RJ, Dalvi A (1997) Anxiety, defense and the elevated plusmaze. Neurosci Biobehav Rev 21:801-810
41. Rodgers RJ, Johnson NJ (1995) Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297-303
42. Rogers H, Hayes AG, Birch PJ, Traynor JR, Lawrence AJ (1990) The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors. J Pharm Pharmacol 42:358-359
43. Rosen JB (2004) The neurobiology of conditioned and unconditioned fear: A neurobehavioral system analysis of the amygdala. Behav Cogn Neurosci Rev 3:23-41
44. Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J (2004) Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci 95:374-380
45. Saitoh A, Yoshikawa Y, Onodera K, Kamei J (2005) Role of deltaopioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats. Psychopharmacology (Berl) 182: 327-334
46. Sharif NA, Hughes J (1989) Discrete mapping of brain Mu and delta opioid receptors using selective peptides: Quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10:499-522
47. Wall PM, Messier C (2001) Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci Biobehav Rev 25:275-286